These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 14708714)

  • 21. HLA-G in melanoma: can the current controversies be solved?
    Chang CC; Ferrone S
    Semin Cancer Biol; 2003 Oct; 13(5):361-9. PubMed ID: 14708716
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HLA-E protects glioma cells from NKG2D-mediated immune responses in vitro: implications for immune escape in vivo.
    Wischhusen J; Friese MA; Mittelbronn M; Meyermann R; Weller M
    J Neuropathol Exp Neurol; 2005 Jun; 64(6):523-8. PubMed ID: 15977644
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of microglia in central nervous system immunity and glioma immunology.
    Yang I; Han SJ; Kaur G; Crane C; Parsa AT
    J Clin Neurosci; 2010 Jan; 17(1):6-10. PubMed ID: 19926287
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HLA-G suppresses proliferation of CD4(+) T-lymphocytes.
    Bainbridge DR; Ellis SA; Sargent IL
    J Reprod Immunol; 2000 Aug; 48(1):17-26. PubMed ID: 10996380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The immunotolerance role of HLA-G.
    Rouas-Freiss N; Khalil-Daher I; Riteau B; Menier C; Paul P; Dausset J; Carosella ED
    Semin Cancer Biol; 1999 Feb; 9(1):3-12. PubMed ID: 10092545
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High numbers of tumour-infiltrating activated cytotoxic T lymphocytes, and frequent loss of HLA class I and II expression, are features of aggressive B cell lymphomas of the brain and testis.
    Riemersma SA; Oudejans JJ; Vonk MJ; Dreef EJ; Prins FA; Jansen PM; Vermeer MH; Blok P; Kibbelaar RE; Muris JJ; Schuuring EM; Kluin PM
    J Pathol; 2005 Jul; 206(3):328-36. PubMed ID: 15887291
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Homozygous HLA-G*0105N healthy individuals indicate that membrane-anchored HLA-G1 molecule is not necessary for survival.
    Casro MJ; Morales P; Rojo-Amigo R; Martinez-Laso J; Allende L; Varela P; Garcia-Berciano M; Guillen-Perales J; Arnaiz-Villena A
    Tissue Antigens; 2000 Sep; 56(3):232-9. PubMed ID: 11034559
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HLA-G and HLA-E: fundamental and pathophysiological aspects.
    Carosella ED; Paul P; Moreau P; Rouas-Freiss N
    Immunol Today; 2000 Nov; 21(11):532-4. PubMed ID: 11221681
    [No Abstract]   [Full Text] [Related]  

  • 29. The evolution of the MHC-G gene does not support a functional role for the complete protein.
    Arnaiz-Villena A; Martinez-Laso J; Castro MJ; Morales P; Moscoso J; Varela P; Gomez-Casado E; Allende LM
    Immunol Rev; 2001 Oct; 183():65-75. PubMed ID: 11782247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human alloreactive CTL interactions with gliomas and with those having upregulated HLA expression from exogenous IFN-gamma or IFN-gamma gene modification.
    Read SB; Kulprathipanja NV; Gomez GG; Paul DB; Winston KR; Robbins JM; Kruse CA
    J Interferon Cytokine Res; 2003 Jul; 23(7):379-93. PubMed ID: 14511464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The non-classical antigens of HLA-G and HLA-E as diagnostic and prognostic biomarkers and as therapeutic targets in transplantation and tumors.
    Seliger B
    Clin Transpl; 2013; ():465-72. PubMed ID: 25095542
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation of alteration of HLA-F expression and clinical characterization in 593 brain glioma samples.
    Feng E; Liang T; Wang X; Du J; Tang K; Wang X; Wang F; You G
    J Neuroinflammation; 2019 Feb; 16(1):33. PubMed ID: 30755240
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HLA-G in the skin--friend or foe?
    Urosevic M
    Semin Cancer Biol; 2007 Dec; 17(6):480-4. PubMed ID: 17981049
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [HLA-G: from feto-maternal tolerance to organ grafting].
    Carosella ED
    Bull Mem Acad R Med Belg; 2009; 164(3-4):87-99; discussion 99-101. PubMed ID: 20120086
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HLA-G expression: immune privilege for tumour cells?
    Cabestre FA; Lefebvre S; Moreau P; Rouas-Friess N; Dausset J; Carosella ED; Paul P
    Semin Cancer Biol; 1999 Feb; 9(1):27-36. PubMed ID: 10092548
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of HLA-G expression in breast cancer tissues.
    Palmisano GL; Pistillo MP; Fardin P; Capanni P; Nicolò G; Salvi S; Spina B; Pasciucco G; Ferrara GB
    Hum Immunol; 2002 Nov; 63(11):969-76. PubMed ID: 12392849
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HLA-G polymorphisms: neutral evolution or novel function?
    Ober C; Aldrich CL
    J Reprod Immunol; 1997 Nov; 36(1-2):1-21. PubMed ID: 9430736
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human leukocyte antigen-G is closely associated with tumor immune escape in gastric cancer by increasing local regulatory T cells.
    Du L; Xiao X; Wang C; Zhang X; Zheng N; Wang L; Zhang X; Li W; Wang S; Dong Z
    Cancer Sci; 2011 Jul; 102(7):1272-80. PubMed ID: 21466615
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extended loci histocompatibility matching in HSCT-Going beyond classical HLA.
    Neuchel C; Fürst D; Tsamadou C; Schrezenmeier H; Mytilineos J
    Int J Immunogenet; 2021 Aug; 48(4):299-316. PubMed ID: 34109752
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cell-cell adhesion mediated by CD8 and human histocompatibility leukocyte antigen G, a nonclassical major histocompatibility complex class 1 molecule on cytotrophoblasts.
    Sanders SK; Giblin PA; Kavathas P
    J Exp Med; 1991 Sep; 174(3):737-40. PubMed ID: 1908512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.